Time to Reconsider the Role of Relative Blood Volume Monitoring for Fluid Management in Hemodialysis by Keane, DF et al.
This is a repository copy of Time to Reconsider the Role of Relative Blood Volume 
Monitoring for Fluid Management in Hemodialysis.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/127858/
Version: Accepted Version
Article:
Keane, DF, Baxter, P orcid.org/0000-0003-2699-3103, Lindley, E et al. (2 more authors) 
(2018) Time to Reconsider the Role of Relative Blood Volume Monitoring for Fluid 
Management in Hemodialysis. ASAIO Journal, 64 (6). pp. 812-818. ISSN 1058-2916 
https://doi.org/10.1097/MAT.0000000000000795
© 2018 by the American Society for Artificial Internal Organs. This is an author produced 
version of a paper published in ASAIO Journal. Uploaded in accordance with the 
publisher's self-archiving policy.
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless 
indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by 
national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of 
the full text version. This is indicated by the licence information on the White Rose Research Online record 
for the item. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Time to reconsider the role of relative blood volume
monitoring for fluid management in hemodialysis
David Keane1,2,3,4, Paul Baxter4, Elizabeth Lindley1,2,3, Sue Pavitt5, Laura Treadgold4
Departments of 1Renal Medicine and 2Medical Physics Leeds Teaching Hospitals NHS Trust,
3NIHR Devices for Dignity Healthcare Technology Co-operative; 4Leeds Institute for
Cardiovascular and Metabolic Medicine, University of Leeds; 5Leeds Dental Institute,
University of Leeds
Abstract
Relative blood volume (RBV) monitoring during hemodialysis has been used to help guide
fluid management for decades, though with little supporting evidence. The technique relies
on the assumption that variation in RBV during fluid removal reflects the capacity for
vascular refilling and that efficient refilling is related to fluid overload. This study
investigated the relationship between RBV variation and bioimpedance-based fluid overload
in  47  stable  hemodialysis  patients.  Mean  treatment  ultrafiltration  volume  (UFV)  was  1.7  L
and RBV reduction was 3.2%/hour. RBV slopes were grouped based on trajectory: flatline
(no decrease); linear decrease; or linear decrease followed by flatline. Fluid overload was
similar (p>0.05) across groups pre-dialysis (1.0, 2.2, 1.6 L respectively) and post-dialysis (-
0.8, -0.1, -0.1 L) while UFV was higher (p>0.05!!!!) in patients with a linear decrease (1.8,
2.5,  1.6  L).  Specific  ultrafiltration  rate  (UFR),  but  not  fluid  overload,  was  associated  with
RBV change over dialysis. At least half the patients in each group finished dialysis fluid-
depleted based on bioimpedance, suggesting the link between refilling and fluid overload is
not as straightforward as previously assumed. These results question the assumptions that the
absence of an appreciable decrease in RBV indicates fluid overload and a rapid fall suggested
fluid depletion.
Introduction
Fluid management is one of the principal functions of hemodialysis. Clinical assessment of
fluid status has been the basis of deciding how much fluid to remove during each treatment,
but it is accepted that this approach is inadequate (1). A number of technologies have been
proposed for objective assessment of fluid status, including measurement of relative blood
volume (RBV). RBV devices measure changes in intravascular fluid status of the blood
passing through the dialysis lines by monitoring the concentration of constituents of whole-
blood, such as hemoglobin or hematocrit. These hemoconcentration markers can be measured
by a number of techniques, including optical absorbance or transmission, the speed of
ultrasound or conductivity but all effectively monitor relative changes in blood water
concentration (2). These simple, non-invasive measurements can detect reductions in blood
volume in real time, offering the potential for prevention of intradialytic hypotension (IDH)
and improved fluid management. However, despite being used in hemodialysis for almost 30
years, there is still no robust evidence as to how the measurements can be used in practice.
There are two major assumptions underpinning the use of RBV in hemodialysis. Firstly, that
the hemoconcentration observed in blood passing through the dialysis lines reflects the
relative change in the concentration of the whole blood volume. This is valid as long as both
the amount of the marker being measured and the distribution of this marker are constant
throughout the measurement session (3). Hemolysis, blood leaks or blood transfusions during
hemodialysis could affect the total amount of the marker, but these are not common. Because
capillaries and the central circulation have different concentrations of red blood cells (known
as the F-cell  ratio),  changes in capillary blood flow during a dialysis session could alter the
distribution of the hemoconcentration marker (4).
Secondly, for the technology to be used for fluid management there must be a relationship
between RBV changes and fluid status. A constant or increasing RBV is widely interpreted as
a sign that the rate of refilling of the vascular space from the interstitium matches or exceeds
the  rate  of  fluid  removal,  indicative  of  interstitial  fluid  overload,  while  reductions  in  RBV
suggest that vascular refilling cannot compensate for fluid removal, indicative of reduced
interstitial fluid volumes. When these principles are applied to real-time monitoring of RBV,
often as part of a feedback controlled mechanism, reducing ultrafiltration rates in response to
RBV reductions can reduce the number of hypotensive episodes (5). When applied to target
weight  management,  RBV  values  that  are  relatively  constant  during  a  dialysis  session  are
assumed to indicate that the patient is fluid overloaded, typically leading to reductions in
target weight until there is an acceptable drop in RBV over a dialysis session (6). However,
there are no clear definitions of the different trajectories and good evidence in support of this
approach is lacking. The only randomized controlled trial looking at the effect of RBV based
fluid management on hard outcomes actually showed increased mortality in the group
managed with RBV (7).
Bioimpedance is another simple, non-invasive technology that can provide information on
fluid status. The Body Composition Monitor (BCM; Fresenius Medical Care, Bad Homburg,
Germany) uses a model specifically designed for renal patients (8) to give an estimate of fluid
overload, which the device names “overhydration” (OH) (we will use OH to specifically
describe the parameter measured by BCM and ‘fluid overload’ to describe the physiological
state). BCM-measured OH has been well validated (9) and shown to be directly associated
with morbidity and mortality in hemodialysis patients (10). Although experience and clinical
judgment is required when interpreting BCM data, it is less subjective than the interpretation
of changes in RBV
RBV  and  BCM  are  measuring  two  distinct  compartments  -  relative  fluid  volumes  in  the
circulation  and  fluid  in  the  tissue  respectively  -  and  they  have  the  potential  to  be
complementary techniques. This study aimed to exploit the greater evidence base
underpinning BCM-based fluid management to try to improve our understanding of how
RBV can inform fluid management.
Methods
Subjects
This study is a subanalysis of a study analysing the validity of alternative BCM measurement
protocols (11) and is exploratory in nature, so no formal sample size calculation was
performed. A cohort of 47 stable hemodialysis patients was recruited, being over 18 years old
and having no apparent localised fluid accumulations. Hemodialysis prescriptions were for
regimes of three sessions of four hours per week, dialysate temperature was 36ࣙC, sodium
was 137mmol/L as standard and patients were free to eat and drink as they desired.
Data collection
Bioimpedance measurements with the BCM were made before dialysis according to
manufacturer’s instructions. Measurements were checked visually for artefacts, and repeated
until the difference in BCM-measured OH was no greater than 0.2 L between readings. Post-
dialysis OH was calculated as pre-dialysis OH minus the change in weight of the patient over
the dialysis session.
RBV measurements were made using the Crit-Line III Monitor (Hema-metrics, Kaysville,
UT, USA). The RBV results from each hemodialysis session were downloaded to allow
analysis. Device calibration was checked monthly using a verification filter. Planned and
achieved ultrafiltration volumes were recorded.
Data analysis
RBV was defined using the percentage reduction in RBV normalised for time in hours
ǻRBV/h). Each RBV slope was characterised based on the approach set out by Lopot et al.
(6) (fig. 1) using a value of  the ǻRBV/h slope cut-off (Scut-off) to distinguish slopes.
A) Flat-line: ‘A’ slopes are characterised by a flat line throughout a hemodialysis
session, with a maximum slope of  Scut-off .
B) Late reduction: ‘B’ slopes are characterised by a flat slope over an initial period of the
hemodialysis session (with a maximum slope of Scut-off for at least one hour) followed
by a  more  rapid  reduction  in  blood  volume for  the  remainder  of  the  session  (with  a
minimum slope of Scut-off).
C) Linear reduction: ‘C’ slopes are characterised by a linear reduction in blood volume
throughout the hemodialysis session (with a minimum slope of Scut-off)
D) Early reduction: ‘D’ slopes are the inverse of ‘B’ slopes and are characterised by an
initial rapid blood volume slope (with a minimum slope of Scut-off for at least one
hour) followed by a flat slope for the rest of the session (a maximum slope of Scut-off)
Manufacturer’s guidance for distinguishing between slope groups A to D  use a value for Scut-
off of  3% and this  was  also  the  basis  of  the  fluid  management  strategies  in  the  CLIMB trial
(7). Other ways of distinguishing groups have been used that vary quite significantly from the
manufacturer’s proposal,  notably the use by Sinha et  al.  of a conservative value of Scut-off of
1.5% (12).
In addition to using ǻRBV/h as the basis of categorising each treatment session, associations
between the value itself and other variables were explored.
Statistical analysis: Pre-  and  post-dialysis  OH,  body  mass  index  (BMI),  ǻRBV/h  and
ultrafiltration  parameters  (UFV,  UFV  normalised  by  body  weight  -  specific  UFV  -  and
ultrafiltration rate (UFR) normalised to body weight - specific UFR) were compared between
the RBV groups by one-way analysis of variance (ANOVA). Because there are numerous
criteria for categorising RBV trajectories, sensitivity analysis was undertaken to re-classify
all the data based on the a conservative definition of Scutoff  as a maximum fall  of 1.3% per
hour (12).
The relationship between ǻRBV/h and pre- and post-dialysis OH and UFV were investigated
using the Pearson correlation coefficient (r).
Results
The characteristics of the included subjects can be seen in table 1. Treatment sessions were
all completed without any recorded symptoms or interventions. There was only one patient in
the ‘B’ group, so for analysis ‘B’ and ‘C’ slope groups were combined as representing blood
volume dynamics following classic Guyton physiology (13).
There was no difference in pre- or post-dialysis OH between the different slope groups, but
UFV was higher in the ‘B’&’C’ group, both in the primary and sensitivity analysis (table 2).
There was no association between trajectory and BMI.
The plots of pre- and post-dialysis BCM-measured OH by RBV category confirm that there is
no discernible difference in OH pattern between the groups (fig. 2). Across all categories
there were subjects who finish dialysis fluid depleted as measured by BCM.
There was no association between the rate of reduction of the RBV slope (ǻRBV/h) and
either pre- or -post dialysis OH, but the specific UFR was positively associated with ǻRBV/h
(r=0.29, p=0.045; figure 3).
Discussion
These results question some commonly-held views on the association between changes in
RBV during dialysis and fluid status. Although there is no gold-standard assessment of
excess fluid, BCM assessments of fluid status have well described measurement
characteristics and reproducibility (14). Furthermore, hemodialysis patients with BCM-
measured OH that is too high or too low (15) have reduced survival. Maduell et al. have
previously demonstrated a relationship between RBV and BCM-measured OH (16). Here we
build on Maduell’s work by evaluating the impact of fluid management strategies based on
common approaches to interpreting RBV on fluid status using the BCM.
‘A’ slopes (or flat-lines) in response to ultrafiltration are generally assumed to suggest that
fluid excess is driving vascular refilling and the maintenance of RBV. Based on this
assumption, a reduction in target weight would normally be indicated. The data here suggests
that subjects finishing dialysis up to 2 L fluid-depleted, as measured by BCM, were classed
as having an ‘A’ shaped curve. Even using conservative definitions of the curves, over half
the subjects with an ‘A’ slope finished hemodialysis fluid depleted (fig. 2). Reducing target
weight in individuals with ‘A’ slopes would lead to excessive post-dialysis fluid depletion
and risk of IDH. There are studies that have demonstrated benefit from reducing target
weights in patients with a flat-line (17,18), but the outcomes presented are limited, such as
achievement of reduced weight which, in itself, does not necessarily translate to better
outcomes. It  is  possible that fluid management based on these principles is  not dissimilar to
probing for dry weights.
The ‘A’ slopes in patents finishing dialysis fluid depleted could be explained by a non-
constant F-cell ratio. Hemodialysis is associated with fluid shifts from the microcirculation to
the macrocirculation to maintain central blood volume (19). Mitra et al. showed that this
increases RBV values, in their study by about 8%, and this effect could mask real reductions
in absolute blood volume. Postural changes and eating have also been shown to affect the F-
cell ratio (3).
‘B’  and  ‘C’  slopes  are  thought  to  indicate  an  individual  is  close  to  target  weight,  although
clear guidance on how this is translated into practice is lacking. This could be based on
defining individual RBV limits for a patient, below which patients have previously become
symptomatic (20). Alternatively, the appearance of an acute reduction in the RBV trajectory
(21) has been suggested as indicating failing vascular refill and therefore proximity to target
weight. However, with both these methods there is significant uncertainty in these markers.
The data from this study underlined this uncertainty. Although the rate of change in RBV is
often used to adjust target weight, figure 3 shows there was no significant association
between ǻRBV/h and pre- or post-dialysis OH. However, patients in group B&C did have
greater UFV and specific UFR than the other groups, and ǻRBV/h was associated with
specific UFR suggesting that the rate of fluid removal has a greater influence on RBV than
the interstitial fluid volume driving vascular refilling.
‘D’ shaped curves have been associated with increased ultrafiltration volume (22), higher
fluid overload (23) and treatments where patients became symptomatic (24). There are
conflicting reports about how common these measurements are, from less than 1% in an adult
unit (25) to 91% in a paediatric unit (26). The data here demonstrate clearly that these
changes cannot always be physiological. Figure 4 shows the RBV data from four subjects in
this study with ‘D’ shaped curves. Despite the apparent large reduction in RBV, the
treatments was completed without complications and stable blood pressures. In each of these
cases, the reduction in RBV over the initial hour would suggest much greater fluid loss from
the circulation than was removed by ultrafiltration, using estimated absolute blood volume
from anthropometry (27). It is notable that in all these cases, the baseline hematocrit
measured by the Crit-line was very low. Although we did not have reference blood samples
from the same session for hematocrit comparison, routine, laborartory monthly blood data
from sessions preceding and following the sessions monitored by Crit-line suggest all these
patients’ hematocrit was stably in the normal range, suggesting a measurement artefact. An
artefactually low initial hematocrit would correspond with overestimation of reductions in
RBV, as observed here.
A common feature of all of the groups is high variation. Plasma refilling coefficient varies
markedly between individual patients undergoing hemodialysis (22, 28), with a removal of 2
L of fluid over 1 hour giving anywhere between 0.7% and 21.9% reduction in RBV (29). It
then  follows  that  critical  RBV  limits  will  also  vary  between  subjects  (30).  Removing  the
inter-subject variability by defining individual critical RBV limits improves the reliability
and this has, in one study, been shown to predict IDH events with a variation of less than 5%
RBV (31), but there still remains significant intra-individual variation in the RBV response to
ultrafiltration  (32).  Concurrent  use  of  BCM and RBV allows  the  opportunity  to  account  for
some of the variability between different measurement sessions and absolute blood volume
(ABV) measurements could further explain intra-subject variation.
This uncertainty may, in part, explain the lack of good interventional studies supporting the
use of RBV-based fluid management. The one published RCT that used mortality as an
outcome, the Crit-Line Intradialytic Monitoring Benefit (CLIMB) study, actually showed a
negative result (7). Non-interventional studies have been more promising. Sinha et al.
analysed patients enrolled in the DRIP trial, investigating probing for dry weight (12). They
reported a number of observations in support of the use of RBV slope for assessment of dry
weight, including the fact that RBV slopes steepen upon dry weight probing and that baseline
RBV slope is associated with weight loss and reduction in blood pressure after probing.
These findings support the physiological basis of RBV monitoring but provide no evidence
for the benefit of using the technology to guide decision making. It is also worth pointing out
that dry weight determined from probing can be much lower than the weight at normal fluid
status.
RBV measurements can also be used to automatically adjust the ultrafiltration rate using a
feedback loop to attempt to avoid IDH. Results from randomised trials using this approach
have been mixed. RBV-guided ultrafiltration in hypotensive prone patients has previously
been shown to reduce the number of treatments with IDH (33), while more recently Leung et
al. demonstrated no benefit from feedback control technology (34). When Antlanger et al.
enrolled fluid overloaded patients and applied a rapid dry weight reduction protocol, they
observed a lower rate of complications in the study group treated by ultrafiltration regulation
and temperature regulation combined than in the conventional dialysis group, while
ultrafiltration regulation and conductivity regulation was worst (35).
Measurement  of  ABV  (36)  offers  the  possibility  of  removing  some  of  the  inherent
uncertainty in the use of RBV measurements. ABV measurements have been used to
demonstrate that vascular refilling is dependent on UFV but not fluid overload, consistent
with the results presented here (37), and a small pilot study has demonstrated that use of an
ABV threshold to guide target weight management reduces IDH (38).
Our study was exploratory in nature and was not powered for outcomes; the relatively small
numbers  of  participants  in  each  group  is  a  weakness.  However,  at  an  individual  level,  our
data show that the commonly held view assumption that a low ǻRBV/h (an ‘A’ slope) is not
a  reliable  indicator  of  fluid  overload.  There  is  a  real  need  for  further  studies,  using  well
defined approaches to RBV-based fluid management, to evaluate the impact on outcomes.
Conclusions
These data call into question the assumption that patients with a flat-line RBV are fluid
overloaded and require a reduction in target weight and that current use of RBV for fluid
management could be leaving patients at risk of complications associated with low BCM
measured-OH (15, 39). There is a need for further observational studies that use objective and
reproducible classifications in the management of RBV. The complimentary nature of BCM,
ABV and RBV supports further studies into how the information from both tests can be
combined.
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Figure/table legends
Figure 1: Characteristic trajectories of relative blood volume (RBV) curves
time
RBV
A
BC
D
Figure 2: (a) Data from the primary analysis and (b) from the sensitivity analysis showing pre
and post BCM-measured OH for patients with relative blood volume plots of different
trajectory
Figure 3: Association of the change in relative blood volume per hour (ǻRBV/h) with (a) pre-
and (b) post BCM-measured OH and (c) ultrafiltration volume (Pearson’s r and p-value: 0.22,
0.15; 0.18, 0.22; 0.29, 0.045)
Figure 4: Example of a ‘D’ shaped relative blood volume curve with a reduction over the first
hour that would be associated with a far greater drop in blood volume than the volume removed
by ultrafiltration
Characteristic N=47
Age (years) 60 (16)
Height (m) 1.70 (0.12)
Weight (kg) 81 (23)
BMI (kg/m2) 29 (7)
Male sex 27 (58%)
Dialysis vintage (months) 30 (6)
Pre-dialysis SBP/DBP (mmHg) 137 (24) / 69 (14)
Post-dialysis SBP/DBP (mmHg) 128 (27) / 68 (14)
Crit-line Pre-dialysis haematocrit (%) 28 (5)
ǻRBV at treatment end (%) 12 (9)
Table 1: Subject demographics. Data are mean (standard deviation) for normal data and
number (%) for categorical data. SBP is systolic blood pressure and DBP is diastolic blood
pressure
A B & C D p-value
Primary
analysis
N 16 15 16 -
Pre-dialysis OH (L) 1.0 (1.4) 2.2 (1.4) 1.6 (1.7) 0.1
Post- dialysis OH (L) -0.8 (1.4) -0.1 (1.4) -0.1 (1.6) 0.3
UF volume (L) 1.8 (0.8) 2.5 (1.0) 1.6 (0.9) 0.02*
Specific UF volume (mL/kg) 23 (14) 31 (11) 21 (11) 0.06
Specific UF rate (mL/kg/h) 6 (4) 9 (4) 6 (3) 0.03*
ǻRBV at treatment end (%) 6 (3) 15 (6) 15 (13) 0.01*
BMI (kg/m2) 30 (7) 27 (6) 28 (6) 0.3
Sensitivity
analysis
N 8 22 17 -
Pre-dialysis OH (L) 1.0 (1.6) 1.9 (1.4) 1.5 (1.8) 0.3
Post- dialysis OH (L) -1.0 (1.4) -0.2 (1.4) -0.3 (1.7) 0.5
UF volume (L) 1.6 (0.7) 2.3 (0.9) 1.6 (0.8) 0.02*
Specific UF volume (mL/kg) 13 (20) 27 (21) 19 (24) 0.3
Specific UF rate (mL/kg/h) 4 (6) 8 (6) 5 (6) 0.2
ǻRBV at treatment end (%) 4 (3) 13 (6) 14 (12) 0.02*
BMI (kg/m2) 31 (6) 28 (6) 29 (7) 0.6
Table 2: Pre- and post-dialysis BCM-measured OH, ultrafiltration (UF) volume, specific
UF volume, specific UF rate and BMI by slope group. Data is mean (standard deviation)
and the p-value relates to differences between the three groups based on ANOVA. *
indicates p<0.05 for differences between groups B&C and D only using pairwise testing
with Bonferroni correction for multiple testing
